Oncocyte (OCX) director Last bought 20,000 shares for $17.4K at $0.87
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Andrew J. Last (director at Oncocyte Corporation, OCX) reported that they bought 20,000 shares for $17.4K at $0.87 on Aug 17, 2022. After these transactions the filing shows 70,170 shares held directly.
- Reporting person
- Last Andrew J.
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Aug 17, 2022 | Open-market purchase (P) | Common Stock, no par value | +20,000 | $0.87 | $17.4K | 70,170 direct |
Holdings before and after
- Common Stock, no par value: 50,170 to 70,170 direct
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Last report in this OCX Form 4?
Andrew J. Last (director at Oncocyte Corporation, OCX) reported that they bought 20,000 shares for $17.4K at $0.87 on Aug 17, 2022. After these transactions the filing shows 70,170 shares held directly.
How many OCX shares does Last hold after this filing?
The filing shows 70,170 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for OCX
Earlier insider filings at OCX
- Aug 18, 2022SEC Form 4: Andrews Ronald Asbury bought $38,400 worth of shares (40,000 units at $0.96), increasing direct ownership by 14% to 333,212 units
- Aug 18, 2022SEC Form 4: Ross Douglas T. was granted 150,000 shares, increasing direct ownership by 738% to 170,317 units
- Aug 18, 2022SEC Form 4: Paulsen Gisela was granted 525,000 shares, increasing direct ownership by 3,182% to 541,500 units
- Aug 18, 2022SEC Form 4: Last Andrew J. was granted 10,000 shares, increasing direct ownership by 25% to 50,170 units
- Aug 18, 2022SEC Form 4: Kingsley Alfred D bought $9,700 worth of shares (10,000 units at $0.97) and was granted 10,000 shares, increasing direct ownership by 5% to 414,111 units
Quantisnow market dataAMEX
OCX
Oncocyte Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
Get push alerts for OCX
Full OCX profile on Quantisnow Follow OCX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time